A positive association between interleukin-1 receptor antagonist and insulin resistance in postmenopausal women

被引:1
作者
Hwu, Chii-Min [1 ,2 ]
Liou, Hung-Hsiang [3 ]
Lee, Chung-Jen [4 ]
Hsu, Bang-Gee [5 ,6 ]
机构
[1] Taipei Vet Gen Hosp, Sect Endocrinol & Metab, Dept Med, 201,Shi Pai Rd Sec 2,Chung Cheng Bldg 11F, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan
[3] Hsin Jen Hosp, Div Nephrol, Dept Internal Med, New Taipei, Taiwan
[4] Tzu Chi Univ Sci & Technol, Dept Nursing, Hualien, Taiwan
[5] Buddhist Tzu Chi Gen Hosp, Div Nephrol, Dept Med, Hualien, Taiwan
[6] Tzu Chi Univ, Sch Med, Fac Med, Hualien, Taiwan
关键词
Association; insulin resistance; interleukin 1 receptor antagonist protein; postmenopause; women; C-REACTIVE PROTEIN; TYPE-2; DIABETES-MELLITUS; WHITEHALL II; INDIVIDUALS; SENSITIVITY; BIOMARKERS; OBESITY; IMMUNE; RISK;
D O I
10.1080/09513590.2018.1427225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The purpose of this study was to determine whether higher circulating interleukin-1 receptor antagonist (IL-1Ra), an anti-inflammatory cytokine, was associated with insulin resistance in postmenopausal women.Methods: We measured IL-1Ra concentrations in 160 naturally postmenopausal women without a history of diabetes mellitus. A Pearson coefficient was computed to assess the relationship between plasma IL-1Ra and homeostasis model assessment of insulin resistance (HOMA-IR). The association between HOMA-IR and IL-1Ra plasma level above the median was assessed by logistic regression. Linear regression was used to explore the determinants of IL-1Ra plasma levels.Results: A significant positive correlation existed between IL-1Ra and HOMA-IR (r=0.42, p<.0001). The upper-tertile group of HOMA-IR was associated with approximately 4.5-fold increased risk of plasma IL-1Ra level above the median compared with the low-tertile group after adjustments. When multiple correlates were entered into the regression model simultaneously, only Log HOMA-IR remained significantly related to Log IL-1Ra (p=.007).Conclusions: Our results demonstrated a positive association between plasma IL-1Ra and insulin resistance in postmenopausal women. This analysis suggested that insulin resistance was an important determinant of circulating IL-1Ra for these women.
引用
收藏
页码:574 / 578
页数:5
相关论文
共 23 条
  • [1] Accelerated Increase in Serum Interleukin-1 Receptor Antagonist Starts 6 Years Before Diagnosis of Type 2 Diabetes Whitehall II Prospective Cohort Study
    Carstensen, Maren
    Herder, Christian
    Kivimaeki, Mika
    Jokela, Markus
    Roden, Michael
    Shipley, Martin J.
    Witte, Daniel R.
    Brunner, Eric J.
    Tabak, Adam G.
    [J]. DIABETES, 2010, 59 (05) : 1222 - 1227
  • [2] The Roles of IL-6, IL-10, and IL-1RA in Obesity and Insulin Resistance in African-Americans
    Charles, Bashira A.
    Doumatey, Ayo
    Huang, Hanxia
    Zhou, Jie
    Chen, Guanjie
    Shriner, Daniel
    Adeyemo, Adebowale
    Rotimi, Charles N.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (12) : E2018 - E2022
  • [3] Mechanisms Linking Inflammation to Insulin Resistance
    Chen, Li
    Chen, Rui
    Wang, Hua
    Liang, Fengxia
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [4] The role of interleukins in insulin resistance and type 2 diabetes mellitus
    Feve, Bruno
    Bastard, Jean-Philippe
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2009, 5 (06) : 305 - 311
  • [5] Franck N, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113203, 10.1371/journal.pone.0107487]
  • [6] Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes
    Grossmann, Vera
    Schmitt, Volker H.
    Zeller, Tanja
    Panova-Noeva, Marina
    Schulz, Andreas
    Laubert-Reh, Dagmar
    Juenger, Claus
    Schnabel, Renate B.
    Abt, Tobias G. J.
    Laskowski, Rafael
    Wiltink, Joerg
    Schulz, Eberhard
    Blankenberg, Stefan
    Lackner, Karl J.
    Muenzel, Thomas
    Wild, Philipp S.
    [J]. DIABETES CARE, 2015, 38 (07) : 1356 - 1364
  • [7] Treatment with the PPARγ agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome
    Halvorsen, Bente
    Heggen, Eli
    Ueland, Thor
    Smith, Camilla
    Sandberg, Wiggo J.
    Damas, Jan K.
    Otterdal, Kari
    Tonstad, Serena
    Aukrust, Pal
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2010, 162 (02) : 267 - 273
  • [8] Anti-inflammatory cytokines and risk of type 2 diabetes
    Herder, C.
    Carstensen, M.
    Ouwens, D. M.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 : 39 - 50
  • [9] Biomarkers of subclinical inflammation and increases in glycaemia, insulin resistance and beta-cell function in non-diabetic individuals: the Whitehall II study
    Herder, Christian
    Faerch, Kristine
    Carstensen-Kirberg, Maren
    Lowe, Gordon D.
    Haapakoski, Rita
    Witte, Daniel R.
    Brunner, Eric J.
    Roden, Michael
    Tabak, Adam G.
    Kivimaki, Mika
    Vistisen, Dorte
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2016, 175 (05) : 367 - 377
  • [10] Prehypertension is associated with insulin resistance
    Hwu, C. -M.
    Liou, T. -L.
    Hsiao, L. -C.
    Lin, M. -W.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2009, 102 (10) : 705 - 711